ArticleInflammopharmacology2025
Trypsin inhibitor isolated from the seeds of Inga laurina (sw.) Willd decreased inflammatory and nociceptive responses in mice.
Article in Inflammopharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Serine proteases (SP) are a defence mechanism for neutrophils, they induce recruitment and activation of immune cell, cytokine production and degradation of the extracellular matrix. However, the deregulated activity of SP or their inhibitors can lead to the development of inflammatory diseases. Natural inhibitors of serine proteases (iSP) from plants of the Fabaceae family have shown potential as modulators of inflammation and Inga laurina is a species that has an iSP (ILTi) in its seeds. The aim of this study was to evaluate the anti-inflammatory and antinociceptive response of this inhibitor. The assays performed were leukocyte infiltrate, mast cell degranulation, paw oedema, writhing abdominal, formalin and the determination of cytokines levels were the assays realized. Male Swiss mice, 18-25 g, were distributed in the groups Saline (10 mL/kg); Dexamethasone (0.5 mg/kg); ILTi (0.3; 3 or 30 mg/kg); Dipyrone (500 mg/kg), in the abdominal writhing assay and Morphine (5 mg/kg), in the formalin test. Cytokine levels were determined by flow cytometry. The results showed that ILTi (0.3 mg/kg) reduced the total leukocytes (64.5%) and polymorphonuclear cell infiltrate (74%), mast cell degranulation (30.2 ± 3.2%) and inhibited paw oedema in all times at the doses of 3 and 30 mg/kg. In addition, ILTi reduced IL-6 (35.6%) and TNF (79.2%) levels. In pain models, ILTi attenuated abdominal writhing (56.4%) and paw licking time in both phases (neurogenic, 43.2%; inflammatory, 23. 4%). Cytokine analysis revealed a decrease in IL-6 (35.6%) and TNF (79.2%) levels. These findings indicate that ILTi exhibits anti-inflammatory and antinociceptive effects, possibly through modulation of protease-mediated pathways or the blocking the activation of protease-activated receptors.
Indexed as
Identifiers
41105343What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.